BIT

0.00%

2.2¢ biotron limited

$10 Billion Deal, page-9936

First 9936 Last

Share
Profile

Follow
stockman49

659 Posts.

101

23/07/22

15:29

Post #: 62690593
Share

Mesoblast had a trial into covid run for them at no cost by a section of US gov agency. It was also a slow start up to get it going. I wonder if something similar may be on the cards here with BIT 225. The MSB trial was apparently worth in the order of 50mil.

Originally posted by GiddyYup: ↑

Its now almost 2 months since the last announcement and the vague comments about funding. None of the "any day now" predictions of a deal have proven correct although they provide something to talk about in the absence of any actual new information.

More importantly this coming week marks 3 months since the last quarterly (Apr 26) which inferred that funding should run out sometime around late Oct. Unless something very significant has changed the next report may need to contain a very important declaration, ie that the company has insufficient funds to operate through the next quarter. Whilst most shareholders are presumably aware of this situation, the fact that such a declaration may need to be put in writing to the market may come as a bit of a surprise to many. It shouldn't but it might and there is little doubt it would be akin to a big red flashing light around the stock.

Given the above I'm going to assume that management are smart enough to be on the front foot and not just painfully announce that they are almost out of money but not mention any sort of plan. As such the next week may be quite exciting but may finally reveal some uncomfortable truths. The options as I see them are as follows:

a) Management announce a partner or grant that everybody wants and as I think was inferred in the last announcement. Yay, good times.
b) Capital raising, either a rights issue or placement. Both are contrary to previous guidance, ie non-equity funding. Downward price pressure but not terrible. Sometimes you don't get what you want but what you need.
c) No plan..... ummmmmm?

So the upcoming week will be very exciting because it may be that the veil is finally pulled back and there will likely either be a deal, a capital raising or complete chaos.

Now consider the continuous disclosure rules and (a) is starting to look quite unlikely as the short term answer. I'm hoping for the sake of all shareholders (c) is not even an option under consideration for management so it looks exceedingly likely that we will shortly see a capital raising announced.

So my bet is that we will shortly see a renounceable rights issue announced. Probably with attached options as an incentive. I know some didn't like it when I dared to raise this in late May because back then it was considered a capital offense to talk about any alternative to the party line of a background bidding war and a deal "any day now" but lets face it, reality is no amount of wishing are chasing away the dissenting voices has made this happen.

Lets still hope for a great partner deal or grant but lets be honest about where we are at and how soon the company will need to reveal its hand. Regulatory requirements are about to force the smoke to clear. What will we see? Exciting times.

Expand

BIT Price at posting: 7.1¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

TYP

Tryptamine psilocin treatment found safe in IV infusion during early stage trial

M4M

Macro and Norden set up transport solutions initiative for West Pilbara

ASX Market Open: ASX set for red Friday after flat night in Wall Street | 18 Oct

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SGR

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

TLX

Telix Pharmaceuticals' quarterly revenue exceeds AU$200M

YAL

Yancoal Australia reports strong Q3 financials

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

THB

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

There are more pages in this discussion • 3,451 more messages in this thread...

First 9936 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change 0.000(0.00%)		Mkt cap ! $19.85M

Open	High	Low	Value	Volume
2.2¢	2.3¢	2.2¢	$8.562K	389.1K

Buyers (Bids)

No.	Vol.	Price($)
1	228	2.2¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	1991719	1

View Market Depth

No.	Vol.	Price($)
1	228	0.022
5	507857	0.021
11	966273	0.020
10	1806701	0.019
10	1719892	0.018

Price($)	Vol.	No.
0.023	1991719	1
0.024	234999	2
0.025	150000	1
0.026	53847	1
0.027	169508	3

Last trade - 14.47pm 18/10/2024 (20 minute delay)

BIT (ASX) Chart

$10 Billion Deal, page-9936

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Tryptamine psilocin treatment found safe in IV infusion during early stage trial

Macro and Norden set up transport solutions initiative for West Pilbara

ASX Market Open: ASX set for red Friday after flat night in Wall Street | 18 Oct

Talga Group wins key permit for flagship graphite mine in Sweden

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

Telix Pharmaceuticals' quarterly revenue exceeds AU$200M

Yancoal Australia reports strong Q3 financials

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

$10 Billion Deal, page-9936

Top Stories

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Tryptamine psilocin treatment found safe in IV infusion during early stage trial

Macro and Norden set up transport solutions initiative for West Pilbara

ASX Market Open: ASX set for red Friday after flat night in Wall Street | 18 Oct

Talga Group wins key permit for flagship graphite mine in Sweden

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

Telix Pharmaceuticals' quarterly revenue exceeds AU$200M

Yancoal Australia reports strong Q3 financials

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News